DGX · Quest Diagnostics Incorporated
$209.882026-07-21Sector: Healthcare; Industry: Medical - Diagnostics & Research; Sub-Industry: Health Care Services
Intrinsic Value Range Comparison · Mulya.ai
Base · active
$126
-39.8% vs market
Mulya.ai vs Analyst IV Comparison?
Mulya.ai IV range ($125 · $195) Analysts Range ($210 · $235) Fundamentals · historical + forward · baseitalics = DCF projection
| Period | Revenue | Rev Gr ? | Ops M% ? | Tax Rate ? | NOPAT ? | Reinvest ? | FCFF ? | WACC% ? | PV FCFF ? | ROIC ? | Inv. Cap ? | EPS ? | P/E |
|---|
| 2024.Q1 | $9.3B | — | 13.6% | 21.7% | $988MM | −$738MM | $250MM | 6.7% | — | 9.1% | $10.8B | $7.63 | — |
| 2024.Q4 | $9.3B | 0.0% | 13.6% | 22.9% | $973MM | −$2.3B | −$1.3B | 7.2% | — | 8.3% | $12.6B | $7.63 | — |
| 2025.Q1 | $9.9B | 6.7% | 13.6% | 21.9% | $1.1B | −$2.1B | −$1.0B | 7.1% | — | 8.3% | $12.8B | $7.78 | — |
| 2025.Q4 | $9.9B | 0.0% | 13.6% | 23.1% | $1.0B | −$139MM | $896MM | 7.0% | — | 8.0% | $13.1B | $7.78 | — |
| 2026.Q1 | $11.3B | 14.2% | 14.3% | 23.5% | $1.2B | −$142MM | $1.1B | 6.9% | — | 9.3% | $13.4B | $9.14 | 14.6 |
| italics below = DCF projection · 10yr Rev CAGR: 4.7% |
| 2027.Q1 | $12.0B | +6.4% | 14.6% | 23.1% | $1.3B | −$341MM | $1.0B | 7.0% | $939MM | 9.9% | $13.7B | $12.01 | 17.5 |
| 2028.Q1 | $12.5B | +4.5% | 14.6% | 22.8% | $1.4B | −$317MM | $1.1B | 7.1% | $955MM | 10.2% | $14.0B | $12.60 | 16.7 |
| 2029.Q1 | $13.1B | +4.8% | 14.6% | 22.4% | $1.5B | −$479MM | $1.0B | 7.3% | $819MM | 10.4% | $14.5B | $13.27 | 15.8 |
| 2030.Q1 | $13.8B | +4.7% | 14.6% | 22.1% | $1.6B | −$367MM | $1.2B | 7.5% | $905MM | 10.6% | $14.9B | $13.96 | 15.0 |
| 2031.Q1 | $14.4B | +4.6% | 14.6% | 21.8% | $1.6B | −$412MM | $1.2B | 7.6% | $866MM | 10.9% | $15.3B | $14.67 | 14.3 |
|
| Term. Yr+ | $18.5B | 4.1% | 11.8% | 20.0% | $1.7B | −$545MM | $1.2B | 8.6% | $12.7B | 13.1% | — | — | — |
Active scenario IV: $126 (-39.8% vs market)